Our new and innovative chromatographic immunoassay technology called Dual Path Platform (DPP®) is ideal for rapid, point-of-care diagnostic testing of a wide variety of analytes.

Learn more


10 U.S. Patents Issued, 14 U.S. Patent Applications, 11 International Patents Issued, 6 International Patents Pending

Learn more


Find a list of journal articles referencing our point-of-care tests and technology.

Learn more

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.